PERSIST: Physician’s Evaluation of Restasis(®) Satisfaction in Second Trial of topical cyclosporine ophthalmic emulsion 0.05% for dry eye: a retrospective review

BACKGROUND: Chronic dry eye disease often requires long-term therapy. Tear film alterations in the setting of dry eye may include reduced tear volume as well as an increase in inflammatory cytokines and osmolarity. Topical cyclosporine ophthalmic emulsion 0.05% (Restasis(®); Allergan Inc, Irvine, CA...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mah, Francis, Milner, Mark, Yiu, Samuel, Donnenfeld, Eric, Conway, Taryn M, Hollander, David A
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2012
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3514052/
https://ncbi.nlm.nih.gov/pubmed/23226002
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S30261
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados